Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 69476 - 69500 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	ARHGAP24	83478	downregulated	Silicon Dioxide analog results in decreased expression of ARHGAP24 mRNA	4q21.23-q21.3	A24194
Silicon dioxide	Approved	ARHGAP25	9938	downregulated	Silicon Dioxide analog results in decreased expression of ARHGAP25 mRNA	2p13.3	A24195
Silicon dioxide	Approved	ARHGAP25	9938	upregulated	Silicon Dioxide analog results in increased expression of ARHGAP25 mRNA	2p13.3	A24194
Silicon dioxide	Approved	ARHGAP29	9411	upregulated	Silicon Dioxide analog results in increased expression of ARHGAP29 mRNA	1p22.1	A24195
Silicon dioxide	Approved	ARHGAP35	2909	downregulated	Silicon Dioxide results in decreased expression of ARHGAP35 mRNA	19q13.32	A24196
Silicon dioxide	Approved	ARHGAP5-AS1	84837	upregulated	Silicon Dioxide analog results in increased expression of ARHGAP5-AS1 mRNA	14q12	A24195
Silicon dioxide	Approved	ARHGEF15	22899	upregulated	Silicon Dioxide analog results in increased expression of ARHGEF15 mRNA	17p13.1	A24195
Silicon dioxide	Approved	ARHGEF2	9181	upregulated	Silicon Dioxide analog results in increased expression of ARHGEF2 mRNA	1q22	A24195
Silicon dioxide	Approved	ARHGEF25	115557	upregulated	Silicon Dioxide analog results in increased expression of ARHGEF25 mRNA	12q13.3	A24194
Silicon dioxide	Approved	ARHGEF26-AS1	100507524	downregulated	Silicon Dioxide analog results in decreased expression of ARHGEF26-AS1 mRNA	3q25.2	A24194
Silicon dioxide	Approved	ARHGEF35	445328	downregulated	Silicon Dioxide analog results in decreased expression of ARHGEF35 mRNA	7q35	A24195
Silicon dioxide	Approved	ARHGEF37	389337	downregulated	Silicon Dioxide analog results in decreased expression of ARHGEF37 mRNA	5q32	A24195
Silicon dioxide	Approved	ARHGEF39	84904	downregulated	Silicon Dioxide analog results in decreased expression of ARHGEF39 mRNA	9p13.3	A24194
Silicon dioxide	Approved	ARHGEF4	50649	upregulated	Silicon Dioxide analog results in increased expression of ARHGEF4 mRNA	2q21.1	A24195
Silicon dioxide	Approved	ARHGEF5	7984	downregulated	Silicon Dioxide analog results in decreased expression of ARHGEF5 mRNA	7q35	A24195
Silicon dioxide	Approved	ARHGEF9	23229	downregulated	Silicon Dioxide results in decreased expression of ARHGEF9 mRNA	Xq11.1	A24196
Silicon dioxide	Approved	ARID3B	10620	upregulated	Silicon Dioxide results in increased expression of ARID3B mRNA	15q24.1	A24196
Silicon dioxide	Approved	ARID5A	10865	upregulated	Silicon Dioxide analog results in increased expression of ARID5A mRNA	2q11.2	A24195
Silicon dioxide	Approved	ARID5B	84159	downregulated	Silicon Dioxide analog results in decreased expression of ARID5B mRNA	10q21.2	A24195
Silicon dioxide	Approved	ARIH2	10425	upregulated	Silicon Dioxide analog results in increased expression of ARIH2 mRNA	3p21.31	A24194
Silicon dioxide	Approved	ARIH2	10425	downregulated	Silicon Dioxide results in decreased expression of ARIH2 mRNA	3p21.31	A24196
Silicon dioxide	Approved	ARL14	80117	upregulated	Silicon Dioxide analog results in increased expression of ARL14 mRNA	3q25.33	A24194
Silicon dioxide	Approved	ARL14	80117	upregulated	Silicon Dioxide results in increased expression of ARL14 mRNA	3q25.33	A24196
Silicon dioxide	Approved	ARL15	54622	downregulated	Silicon Dioxide analog results in decreased expression of ARL15 mRNA	5q11.2	A24195
Silicon dioxide	Approved	ARL17A	51326	upregulated	Silicon Dioxide analog results in increased expression of ARL17A mRNA	17q21.31	A24195

Displaying entries 69476 - 69500 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability